Company Filing History:
Years Active: 1976
Title: Arthur S. Watnick: Innovator in Steroidal Compounds
Introduction
Arthur S. Watnick is a notable inventor based in South Orange, NJ (US). He has made significant contributions to the field of steroidal compounds, particularly through his innovative patent work. His research has implications in the medical field, especially concerning anti-inflammatory treatments.
Latest Patents
Watnick holds a patent for "Azido-4,6-pregnadieno(3,2-c)pyrazoles." This patent describes processes for preparing steroidal 6-azido-4,6-pregnadieno[3,2-c]pyrazoles that exhibit glucocorticoid activity. The preparation involves treating a 6-unsubstituted-4,6-pregnadieno[3,2-c]pyrazole with a halogen azide, followed by further chemical treatments to yield compounds with potent anti-inflammatory properties. Notably, preferred compounds include 6-azido-11.beta.,17.alpha.,21-trihydroxy-20-keto-4,6-pregnadieno[3,2-c]pyrazoles, particularly derivatives that possess enhanced therapeutic effects.
Career Highlights
Watnick's career is marked by his work at Schering Corporation, where he has contributed to the development of innovative pharmaceutical compounds. His expertise in steroidal chemistry has positioned him as a key figure in the research and development of new medications.
Collaborations
Throughout his career, Watnick has collaborated with esteemed colleagues such as Thomas L. Popper and Richard W. Draper. These collaborations have furthered the advancement of research in steroidal compounds and their applications in medicine.
Conclusion
Arthur S. Watnick's contributions to the field of steroidal compounds through his patent work have had a lasting impact on medical research and treatment options. His innovative approaches continue to influence the development of effective anti-inflammatory medications.